Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Clin Pharmacol Ther ; 110(6): 1622-1632, 2021 12.
Article in English | MEDLINE | ID: mdl-34580865

ABSTRACT

A previous study in 356 healthy Finnish volunteers showed that glycochenodeoxycholate 3-O-glucuronide (GCDCA-3G) and glycodeoxycholate 3-O-glucuronide (GDCA-3G) are promising biomarkers of organic anion transporting polypeptide 1B1 (OATP1B1). In the same cohort, we now evaluated the performances of two other OATP1B1 biomarkers, coproporphyrin I (CPI) and III (CPIII), and compared them with GCDCA-3G and GDCA-3G. Based on decreased (*5 and *15) and increased (*14 and *20) function SLCO1B1 haplotypes, we stratified the participants to poor, decreased, normal, increased, and highly increased OATP1B1 function groups. Fasting plasma CPI concentration was 68% higher in the poor (95% confidence interval, 44%, 97%; P = 1.74 × 10-10 ), 7% higher in the decreased (0%, 15%; P = 0.0385), 10% lower in the increased (3%, 18%; P = 0.0087), and 23% lower in the highly increased (1%, 40%; P = 0.0387) function group than in the normal function group. CPIII concentration was 27% higher (7%, 51%; P = 0.0071) in the poor function group than in the normal function group. CPI and CPIII detected poor OATP1B1 function with areas under the precision-recall curve (AUPRC) of 0.388 (95% confidence interval, 0.197, 0.689) and 0.0798 (0.0485, 0.203), and receiver operating characteristic curve (AUROC) of 0.888 (0.851, 0.919) and 0.731 (0.682, 0.776). The AUPRC and AUROC of GCDCA-3G were, however, 0.389 (0.258, 0.563) and 0.100 (-0.0046, 0.204; P = 0.0610) larger than those of CPI, and 0.697 (0.555, 0.831) and 0.257 (0.141, 0.373; P < 0.0001) larger than those of CPIII. In conclusion, these data indicate that plasma CPI outperforms CPIII in detecting altered OATP1B1 function, but GCDCA-3G is an even more sensitive OATP1B1 biomarker than CPI.


Subject(s)
Coproporphyrins/blood , Coproporphyrins/genetics , Liver-Specific Organic Anion Transporter 1/blood , Liver-Specific Organic Anion Transporter 1/genetics , Adult , Biomarkers/blood , Cohort Studies , Female , Finland/epidemiology , Genome-Wide Association Study/methods , Humans , Male , Young Adult
2.
Drug Metab Dispos ; 46(8): 1075-1082, 2018 08.
Article in English | MEDLINE | ID: mdl-29777022

ABSTRACT

In a recent study, limited to South Asian Indian subjects (n = 12), coproporphyrin (CP) I and CPIII demonstrated properties appropriate for an organic anion-transporting polypeptide (OATP) 1B endogenous probe. The current studies were conducted in healthy volunteers of mixed ethnicities, including black, white, and Hispanic subjects, to better understand the utility of these biomarkers in broader populations. After oral administration with 600 mg rifampin, AUC(0-24h) values were 2.8-, 3.7-, and 3.6-fold higher than predose levels for CPI and 2.6-, 3.1-, and 2.4-fold higher for CPIII, for the three populations, respectively. These changes in response to rifampin were consistent with previous results. The sensitivity toward OATP1B inhibition was also investigated by evaluating changes of plasma CP levels in the presence of diltiazem and itraconazole [administered as part of an unrelated drug-drug interaction (DDI) investigation], two compounds that were predicted to have minimal inhibitory effect on OATP1B. Administration of diltiazem and itraconazole did not increase plasma CPI and CPIII concentrations relative to prestudy levels, in agreement with predictions from in vitro parameters. Additionally, the basal CP concentrations in subjects with SLCO1B1 c.521TT genotype were comparable to those with SLCO1B1 c.521TC genotype, similar to studies with probe substrates. However, subjects with SLCO1B1 c.388AG and c.388GG genotypes (i.e., increased OATP1B1 transport activity for certain substrates) had lower concentrations of CPI than those with SLCO1B1 c.388AA. Collectively, these findings provide further evidence supporting the translational value of CPI and CPIII as suitable endogenous clinical probes to gauge OATP1B activity and potential for OATP1B-mediated DDIs.


Subject(s)
Biological Transport/physiology , Biomarkers/metabolism , Coproporphyrins/metabolism , Liver-Specific Organic Anion Transporter 1/antagonists & inhibitors , Organic Anion Transporters/metabolism , Solute Carrier Organic Anion Transporter Family Member 1B3/antagonists & inhibitors , Adult , Biological Transport/drug effects , Coproporphyrins/genetics , Drug Interactions/physiology , Genotype , Humans , Liver-Specific Organic Anion Transporter 1/genetics , Liver-Specific Organic Anion Transporter 1/metabolism , Male , Middle Aged , Organic Anion Transporters/genetics , Rifampin/pharmacology , Solute Carrier Organic Anion Transporter Family Member 1B3/genetics , Solute Carrier Organic Anion Transporter Family Member 1B3/metabolism , Young Adult
3.
Proc Natl Acad Sci U S A ; 114(32): E6652-E6659, 2017 08 08.
Article in English | MEDLINE | ID: mdl-28739897

ABSTRACT

Gram-positive bacteria cause the majority of skin and soft tissue infections (SSTIs), resulting in the most common reason for clinic visits in the United States. Recently, it was discovered that Gram-positive pathogens use a unique heme biosynthesis pathway, which implicates this pathway as a target for development of antibacterial therapies. We report here the identification of a small-molecule activator of coproporphyrinogen oxidase (CgoX) from Gram-positive bacteria, an enzyme essential for heme biosynthesis. Activation of CgoX induces accumulation of coproporphyrin III and leads to photosensitization of Gram-positive pathogens. In combination with light, CgoX activation reduces bacterial burden in murine models of SSTI. Thus, small-molecule activation of CgoX represents an effective strategy for the development of light-based antimicrobial therapies.


Subject(s)
Bacterial Proteins/metabolism , Coproporphyrinogen Oxidase/metabolism , Coproporphyrins/biosynthesis , Photosensitizing Agents/metabolism , Phototherapy , Staphylococcal Skin Infections/enzymology , Staphylococcal Skin Infections/therapy , Staphylococcus aureus/metabolism , Animals , Bacterial Proteins/genetics , Coproporphyrinogen Oxidase/genetics , Coproporphyrins/genetics , Disease Models, Animal , Mice , Staphylococcus aureus/genetics
4.
J Biol Chem ; 288(32): 23488-504, 2013 Aug 09.
Article in English | MEDLINE | ID: mdl-23737523

ABSTRACT

The chlorite dismutases (C-family proteins) are a widespread family of heme-binding proteins for which chemical and biological roles remain unclear. An association of the gene with heme biosynthesis in Gram-positive bacteria was previously demonstrated by experiments involving introduction of genes from two Gram-positive species into heme biosynthesis mutant strains of Escherichia coli, leading to the gene being renamed hemQ. To assess the gene product's biological role more directly, a Staphylococcus aureus strain with an inactivated hemQ gene was generated and shown to be a slow growing small colony variant under aerobic but not anaerobic conditions. The small colony variant phenotype is rescued by the addition of exogenous heme despite an otherwise wild type heme biosynthetic pathway. The ΔhemQ mutant accumulates coproporphyrin specifically under aerobic conditions. Although its sequence is highly similar to functional chlorite dismutases, the HemQ protein has no steady state reactivity with chlorite, very modest reactivity with H2O2 or peracetic acid, and no observable transient intermediates. HemQ's equilibrium affinity for heme is in the low micromolar range. Holo-HemQ reconstituted with heme exhibits heme lysis after <50 turnovers with peroxide and <10 turnovers with chlorite. The heme-free apoprotein aggregates or unfolds over time. IsdG-like proteins and antibiotic biosynthesis monooxygenases are close sequence and structural relatives of HemQ that use heme or porphyrin-like organic molecules as substrates. The genetic and biochemical data suggest a similar substrate role for heme or porphyrin, with possible sensor-regulator functions for the protein. HemQ heme could serve as the means by which S. aureus reversibly adopts an SCV phenotype in response to redox stress.


Subject(s)
Bacterial Proteins/metabolism , Heme/metabolism , Oxidative Stress/physiology , Oxidoreductases/metabolism , Staphylococcus aureus/enzymology , Bacterial Proteins/genetics , Coproporphyrins/genetics , Coproporphyrins/metabolism , Escherichia coli/enzymology , Escherichia coli/genetics , Gene Deletion , Heme/genetics , Oxidoreductases/genetics , Phenotype , Staphylococcus aureus/genetics
5.
J Biol Chem ; 285(37): 28874-82, 2010 Sep 10.
Article in English | MEDLINE | ID: mdl-20610401

ABSTRACT

The feline leukemia virus subgroup C receptor (FLVCR) is a heme export protein that is required for proerythroblast survival and facilitates macrophage heme iron recycling. However, its mechanism of heme export and substrate specificity are uncharacterized. Using [(55)Fe]heme and the fluorescent heme analog zinc mesoporphyrin, we investigated whether export by FLVCR depends on the availability and avidity of extracellular heme-binding proteins. Export was 100-fold more efficient when the medium contained hemopexin (K(d) < 1 pm) compared with albumin (K(d) = 5 nm) at the same concentration and was not detectable when the medium lacked heme-binding proteins. Besides heme, FLVCR could export other cyclic planar porphyrins, such as protoporphyrin IX and coproporphyrin. However, FLVCR has a narrow substrate range because unconjugated bilirubin, the primary breakdown product of heme, was not transported. As neither protoporphyrin IX nor coproporphyrin export improved with extracellular hemopexin (versus albumin), our observations further suggest that hemopexin, an abundant protein with a serum concentration (6.7-25 mum) equivalent to that of the iron transport protein transferrin (22-31 mum), by accepting heme from FLVCR and targeting it to the liver, might regulate macrophage heme export and heme iron recycling in vivo. Final studies show that hemopexin directly interacts with FLVCR, which also helps explain why FLVCR, in contrast to some major facilitator superfamily members, does not function as a bidirectional gradient-dependent transporter. Together, these data argue that hemopexin has a role in assuring systemic iron balance during homeostasis in addition to its established role as a scavenger during internal bleeding or hemolysis.


Subject(s)
Heme/metabolism , Hemopexin/metabolism , Iron/metabolism , Liver/metabolism , Macrophages/metabolism , Membrane Transport Proteins/metabolism , Receptors, Virus/metabolism , Animals , Biological Transport/genetics , Cell Line , Coproporphyrins/genetics , Coproporphyrins/metabolism , Heme/genetics , Hemolysis/genetics , Hemopexin/genetics , Hemorrhage/genetics , Hemorrhage/metabolism , Homeostasis/genetics , Humans , Membrane Transport Proteins/genetics , Protoporphyrins/genetics , Protoporphyrins/metabolism , Rabbits , Rats , Receptors, Virus/genetics , Transferrin/genetics , Transferrin/metabolism
6.
Dermatol Clin ; 5(1): 55-61, 1987 Jan.
Article in English | MEDLINE | ID: mdl-3549079

ABSTRACT

The porphyrias are a group of disorders of heme metabolism that result from partial defects in the several enzymes that control heme biosynthesis. Accumulation of porphyrins or porphyrin precursors in several different patterns results from these defects and biochemically characterizes each specific syndrome. Patterns of cutaneous photosensitivity and associated systemic symptoms among the several porphyrias result from the types of porphyrins or precursors accumulated in each.


Subject(s)
Porphyrias , Skin Diseases , Acute Disease , Coproporphyrins/genetics , Erythropoiesis , Humans , Liver Diseases/genetics , Porphyrias/congenital , Porphyrias/genetics , Protoporphyrins/genetics , Skin Diseases/congenital , Skin Diseases/genetics
7.
J Med Genet ; 21(5): 341-9, 1984 Oct.
Article in English | MEDLINE | ID: mdl-6502649

ABSTRACT

In a family inheriting the hereditary coproporphyria (HCP) gene, where 414 descendants have been traced through six generations and 135 members screened for faecal porphyrins, 27 subjects were found to have inherited the gene as well as the proband. Seven (six female and one male) in retrospect had probably previously suffered from a clinical attack of porphyria. Enzymological studies were carried out on 15 members and two unaffected parents and these results in general agreed with the faecal coproporphyrin readings. Symptomatic illness is low in HCP and is almost always precipitated by drugs known to have an adverse effect on the condition. If the gene is inherited, an attack can occur at any time between puberty and old age, such as in the proband at 84 years. We have detected abnormal faecal coproporphyrin levels in members of this pedigree as young as 12 years and as old as 87 years. Recommendations are given concerning the necessity of tracing relatives who may have inherited the gene and arranging for their biochemical screening and genetic counseling if indicated.


Subject(s)
Coproporphyrins/genetics , Porphyrias/genetics , Porphyrins/genetics , Adolescent , Adult , Age Factors , Aged , Child , Coproporphyrins/metabolism , Feces/metabolism , Female , Genetic Counseling , Humans , Male , Middle Aged , Pedigree , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...